Search Results - "SHALIT, F"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    WFS1 gene as a putative biomarker for development of post-traumatic syndrome in an animal model by Kesner, Y, Zohar, J, Merenlender, A, Gispan, I, Shalit, F, Yadid, G

    Published in Molecular psychiatry (01-01-2009)
    “…Post-traumatic stress disorder (PTSD) is an anxiety disorder that may develop after the experiencing or witnessing of a life-threatening event. PTSD is defined…”
    Get full text
    Journal Article
  2. 2

    Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage by Huberman, M, Shalit, F, Roth-Deri, I, Gutman, B, Brodie, C, Kott, E, Sredni, B

    Published in Journal of neuroimmunology (01-07-1994)
    “…Cytokine secretion by human mononuclear cells (MNC) was investigated in age-matched controls and in patients with Alzheimer's disease (AD). AD patients were…”
    Get more information
    Journal Article
  3. 3

    IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease by Huberman, M., Sredni, B., Stern, L., Kott, E., Shalit, F.

    Published in Journal of the neurological sciences (01-06-1995)
    “…The production of interleukin-2 (IL-2) and interleukin-6 (IL-6) by peripheral blood mononuclear cells (MNC) was assessed in patients with Alzheimer's disease…”
    Get full text
    Journal Article
  4. 4

    Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients by Shalit, F, Sredni, B, Stern, L, Kott, E, Huberman, M

    Published in Neuroscience letters (20-06-1994)
    “…It has been suggested in recent research that interleukin-1 (IL-1) and interleukin-6 (IL-6) play a role in the pathogenesis of Alzheimer's disease (AD)…”
    Get more information
    Journal Article
  5. 5

    A new immunomodulating compound (AS-101) with potential therapeutic application by Sredni, B, Caspi, R. R, Klein, A, Kalechman, Y, Danziger, Y, BenYa'akov, M, Tamari, T, Shalit, F, Albeck, M

    Published in Nature (London) (12-11-1987)
    “…There has been interest in the potential of synthetic compounds to modify immune responses by imitation of cytokine action. Direct administration of…”
    Get full text
    Journal Article
  6. 6

    Synergism between AS101 and PMA in lymphokine production by SREDNI, B, KALECHMAN, Y, SHALIT, F, ALBECK, M

    Published in Immunology (1990)
    “…AS101 [ammonium trichloro (dioxyethylene-o-o') tellurate] has been reported to stimulate normal mouse and human lymphoid cells to proliferate and to produce…”
    Get full text
    Journal Article
  7. 7

    Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis by Huberman, M, Shalit, F, Roth-Deri, I, Gutman, B, Kott, E, Sredni, B

    Published in Journal of the neurological sciences (01-08-1993)
    “…The production of interleukin-3 by peripheral blood mononuclear cells (MNC) was assessed in patients with relapsing multiple sclerosis (MS) in both the active…”
    Get more information
    Journal Article
  8. 8

    The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent by Sredni, B, Albeck, M, Kazimirsky, G, Shalit, F

    “…AS101 [ammonium-trichloro (0,0' dioxyethylene)tellurate] is a new immunomodulator shown previously to stimulate the production of various cytokines in vitro…”
    Get more information
    Journal Article
  9. 9
  10. 10

    T Lymphocyte Subpopulations and Activation Markers Correlate with Severity of Alzheimer's Disease by Shalit, F., Sredni, B., Brodie, C., Kott, E., Huberman, M.

    Published in Clinical immunology and immunopathology (01-06-1995)
    “…In this study we investigated immune-associated antigens of peripheral lymphocytes from patients with Alzheimer's disease (AD). The patients were divided into…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compound by Sredni, B, Caspi, R R, Lustig, S, Klein, A, Kalechman, Y, Danziger, Y, Ben Ya'akov, M, Tamari, T, Shalit, F, Albeck, M

    “…AS-101 (ammonium trichloro[dioxoethylene-O,O'-]tellurate) is a newly developed synthetic compound with immunomodulating properties and minimal toxicity. We…”
    Get more information
    Journal Article
  13. 13

    Modification of cytokine secretion following mild emotional stimuli by Mittwoch-Jaffe, T, Shalit, F, Srendi, B, Yehuda, S

    Published in Neuroreport (27-03-1995)
    “…In the present study, changes in the cytokine system (IL-1 beta, IL-2, IL-3, IL-6 and TNF alpha) were assessed following exposure to mild mood induction…”
    Get more information
    Journal Article
  14. 14

    β-Amyloid peptide induces tumor necrosis factor-α and nitric oxide production in murine macrophage cultures by Shalit, Frances, Sredni, Benjamin, Rosenblatt-Bin, Hannah, Kazimirsky, Gila, Brodie, Chaya, Huberman, Moshe

    Published in Neuroreport (10-11-1997)
    “…We investigated the effect of β-amyloid peptide (βA) on the activation of the murine-derived monocyte/macrophage J774 cell-line. βA induced tumor necrotic…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice by Rosenblatt-Bin, H, Kalechman, Y, Vonsover, A, Xu, R H, Da, J P, Shalit, F, Huberman, M, Klein, A, Strassmann, G, Albeck, M, Sredni, B

    Published in Cellular immunology (25-02-1998)
    “…The immunomodulator AS101 has been previously shown to confer protection upon BALB/c mice infected with the intraerythrocytic parasite Babesia rodhaini (B…”
    Get full text
    Journal Article
  17. 17

    The immunomodulator AS101 restores T sub(H1) type of response suppressed by Babesia rodhaini in BALB/c mice by Rosenblatt-Bin, H, Kalechman, Y, Vonsover, A, Xu, Ren-He, Da, Ji-Ping, Shalit, F, Huberman, M, Klein, A, Strassmann, G, Albeck, M, Sredni, B

    Published in Cellular immunology (25-02-1998)
    “…The immunomodulator AS101 has been previously shown to confer protection upon BALB/c mice infected with the intraerythrocytic parasite Babesia rodhaini (B…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Immunologic effects of AS101 in the treatment of cancer patients by Shani, A, Tichler, T, Catane, R, Gurwith, M, Rozenszajn, L A, Gezin, A, Levi, E, Schlesinger, M, Kalechman, Y, Michlin, H

    “…AS101 [ammonium trichloro(O,O'-dioxyethylene)tellurate] is a new immunomodulator previously shown to stimulate the production of different cytokines in vitro…”
    Get more information
    Journal Article